vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and HCI Group, Inc. (HCI). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $246.2M, roughly 1.5× HCI Group, Inc.). HCI Group, Inc. runs the higher net margin — 39.7% vs -0.8%, a 40.4% gap on every dollar of revenue. On growth, HCI Group, Inc. posted the faster year-over-year revenue change (52.1% vs 9.4%). HCI Group, Inc. produced more free cash flow last quarter ($440.8M vs $36.1M). Over the past eight quarters, HCI Group, Inc.'s revenue compounded faster (9.2% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
HCI Equity Partners is a Washington, DC–based private equity firm with an additional office in Chicago, Illinois.
ASIX vs HCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $246.2M |
| Net Profit | $-2.8M | $97.7M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 58.5% |
| Net Margin | -0.8% | 39.7% |
| Revenue YoY | 9.4% | 52.1% |
| Net Profit YoY | -892.9% | 3679.2% |
| EPS (diluted) | $-0.11 | $7.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $246.2M | ||
| Q3 25 | $374.5M | $216.3M | ||
| Q2 25 | $410.0M | $221.9M | ||
| Q1 25 | $377.8M | $216.4M | ||
| Q4 24 | $329.1M | $161.9M | ||
| Q3 24 | $398.2M | $175.3M | ||
| Q2 24 | $453.5M | $206.2M | ||
| Q1 24 | $336.8M | $206.6M |
| Q4 25 | $-2.8M | $97.7M | ||
| Q3 25 | $-2.6M | $65.5M | ||
| Q2 25 | $31.4M | $66.2M | ||
| Q1 25 | $23.3M | $69.7M | ||
| Q4 24 | $352.0K | $2.6M | ||
| Q3 24 | $22.3M | $5.7M | ||
| Q2 24 | $38.9M | $54.1M | ||
| Q1 24 | $-17.4M | $47.6M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 58.5% | ||
| Q3 25 | -0.9% | 41.9% | ||
| Q2 25 | 7.7% | 42.5% | ||
| Q1 25 | 7.7% | 46.4% | ||
| Q4 24 | -3.9% | 3.6% | ||
| Q3 24 | 7.5% | 8.0% | ||
| Q2 24 | 11.5% | 36.9% | ||
| Q1 24 | -7.0% | 37.5% |
| Q4 25 | -0.8% | 39.7% | ||
| Q3 25 | -0.7% | 30.3% | ||
| Q2 25 | 7.7% | 29.8% | ||
| Q1 25 | 6.2% | 32.2% | ||
| Q4 24 | 0.1% | 1.6% | ||
| Q3 24 | 5.6% | 3.2% | ||
| Q2 24 | 8.6% | 26.2% | ||
| Q1 24 | -5.2% | 23.0% |
| Q4 25 | $-0.11 | $7.29 | ||
| Q3 25 | $-0.10 | $4.90 | ||
| Q2 25 | $1.15 | $5.18 | ||
| Q1 25 | $0.86 | $5.35 | ||
| Q4 24 | $0.02 | $0.32 | ||
| Q3 24 | $0.82 | $0.52 | ||
| Q2 24 | $1.43 | $4.24 | ||
| Q1 24 | $-0.65 | $3.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $1.2B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $1.0B |
| Total Assets | $1.7B | $2.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $1.2B | ||
| Q3 25 | $23.7M | $987.9M | ||
| Q2 25 | $18.4M | $947.2M | ||
| Q1 25 | $8.3M | $754.5M | ||
| Q4 24 | $19.6M | $532.5M | ||
| Q3 24 | $17.3M | $518.8M | ||
| Q2 24 | $12.1M | $445.8M | ||
| Q1 24 | $20.6M | $655.4M |
| Q4 25 | $815.2M | $1.0B | ||
| Q3 25 | $818.2M | $821.8M | ||
| Q2 25 | $823.7M | $758.6M | ||
| Q1 25 | $794.4M | $522.7M | ||
| Q4 24 | $774.6M | $453.3M | ||
| Q3 24 | $766.4M | $455.3M | ||
| Q2 24 | $746.6M | $447.3M | ||
| Q1 24 | $713.2M | $395.7M |
| Q4 25 | $1.7B | $2.5B | ||
| Q3 25 | $1.7B | $2.3B | ||
| Q2 25 | $1.6B | $2.4B | ||
| Q1 25 | $1.6B | $2.3B | ||
| Q4 24 | $1.6B | $2.2B | ||
| Q3 24 | $1.5B | $2.0B | ||
| Q2 24 | $1.5B | $1.9B | ||
| Q1 24 | $1.5B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $444.4M |
| Free Cash FlowOCF − Capex | $36.1M | $440.8M |
| FCF MarginFCF / Revenue | 10.0% | 179.0% |
| Capex IntensityCapex / Revenue | 7.7% | 1.5% |
| Cash ConversionOCF / Net Profit | — | 4.55× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $771.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $444.4M | ||
| Q3 25 | $26.6M | $26.7M | ||
| Q2 25 | $21.1M | $145.0M | ||
| Q1 25 | $11.4M | $162.0M | ||
| Q4 24 | $64.2M | $331.8M | ||
| Q3 24 | $57.3M | $104.1M | ||
| Q2 24 | $50.2M | $-29.0M | ||
| Q1 24 | $-36.2M | $182.0M |
| Q4 25 | $36.1M | $440.8M | ||
| Q3 25 | $66.0K | $25.9M | ||
| Q2 25 | $-7.2M | $144.5M | ||
| Q1 25 | $-22.6M | $160.3M | ||
| Q4 24 | $29.8M | $327.8M | ||
| Q3 24 | $26.8M | $103.2M | ||
| Q2 24 | $16.7M | $-30.1M | ||
| Q1 24 | $-71.6M | $181.0M |
| Q4 25 | 10.0% | 179.0% | ||
| Q3 25 | 0.0% | 12.0% | ||
| Q2 25 | -1.7% | 65.1% | ||
| Q1 25 | -6.0% | 74.1% | ||
| Q4 24 | 9.1% | 202.5% | ||
| Q3 24 | 6.7% | 58.9% | ||
| Q2 24 | 3.7% | -14.6% | ||
| Q1 24 | -21.3% | 87.6% |
| Q4 25 | 7.7% | 1.5% | ||
| Q3 25 | 7.1% | 0.4% | ||
| Q2 25 | 6.9% | 0.2% | ||
| Q1 25 | 9.0% | 0.8% | ||
| Q4 24 | 10.4% | 2.5% | ||
| Q3 24 | 7.7% | 0.5% | ||
| Q2 24 | 7.4% | 0.5% | ||
| Q1 24 | 10.5% | 0.5% |
| Q4 25 | — | 4.55× | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | 0.67× | 2.19× | ||
| Q1 25 | 0.49× | 2.32× | ||
| Q4 24 | 182.29× | 128.41× | ||
| Q3 24 | 2.57× | 18.33× | ||
| Q2 24 | 1.29× | -0.54× | ||
| Q1 24 | — | 3.82× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
HCI
| Insurance Operation | $218.3M | 89% |
| Reciprocal Exchange Operation | $27.0M | 11% |
